Skip to main navigation
Black Diamond Therapeutics
About
Our Vision
At a Glance
Executive Team
Board of Directors
Pipeline
Pipeline
Our Approach
Silevertinib NSCLC
Silevertinib GBM
BDTX-4933
BDTX-4876
Presentations and Publications
Patients
Clinical Trials
Expanded Access
Investors & News
Overview
Press Releases
Events & Presentations
Corporate Governance
Stock Information
SEC Filings
Analyst Coverage
Investor Resources
Join Us
Values
Careers
Biography
Garry Menzel, Ph.D.
Director
Chair of the Audit Committee
Member of the Compensation Committee
Site - Shareholder Tools
Print Page
Print Page
E-mail Alerts
E-mail Alerts
RSS Feeds
RSS Feeds
Contact IR
Contact IR
Search
Search